Eli Lilly, Incyte Announce Positive Results From Pooled Analysis Of Baricitinib

(RTTNews) – Eli Lilly and Company (LLY) and Incyte Corp. (INCY) Friday announced that data from eight Olumiant clinical trials using baricitinib in moderate-to-severe rheumatoid arthritis yielded similar results with placebo-treated patients. At presentations at the Annual European Congress of….

Posted: 2017-06-16 12:01:00

Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.